Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/17/2018
Medicines Containing Huahai's Valsartan API Recalled in EU and U.S.
7/17/2018
Xinhua: China's New Drug for Alzheimer's Completes Phase 3 Trial
7/17/2018
CDE Publicizes Batch 30 of Drug Applications To Be Granted Priority Re...
7/17/2018
State Council Revamps Healthcare Reform Leading Group
7/17/2018
Ascentage Pharma Raises $150 Million in Series C Financing
7/17/2018
China Embraces Another Vaccine Scandal
7/16/2018
Shanghai AIC Officially Terminates Antimonopoly Investigation of the C...
7/16/2018
Healthcare Industry Associations Sign New Framework for Business Ethic...
7/13/2018
Recent Executive Moves
7/13/2018
CNDA Solicits Comments on GMP for Clinical Trial Drugs
7/13/2018
SMIA Mulls Tender for Anticancers as It Plans New Mechanism for Updati...
7/13/2018
NHC Reports on Growing Sector of Private Healthcare Providers in China
7/12/2018
Merck and Xian Janssen to Co-launch Type 2 Diabetes Drug in China
7/12/2018
Sirona Biochem Announces CNDA Approval of SGLT2 Inhibitor for Phase I ...
7/12/2018
CStone's PD-1 Inhibitor CS1003 Gets Clinical Trial Approval in China
7/11/2018
Shanghai Unveils New Open Policy Measures, Benefiting Pharma/MedTech I...
7/11/2018
CDE Solicits Comments on Technical Requirements for Topical Dermatolog...
7/10/2018
Ping An Reportedly to Make Rival Offer for China Biologic
7/10/2018
Transgene Swaps JV Ownership for Stake in Tasly Biopharma
7/10/2018
CNDA Issues Technical Guidelines for Acceptance of Foreign Drug Clinic...
7/10/2018
Updated - NHC Issues Drug Prescription Review Guidelines of Medical In...
7/10/2018
iBio Establishes Strategic Commercial Relationship with CC-Pharming
7/10/2018
China Agrees to Slash Import Duties on Indian Medicines
7/10/2018
U.S. FDA and CNDA Officials Meet to Exchange Anticancer Regulatory Exp...
7/10/2018
Tocagen Closes Licensing Deal with ApolloBio for Immunotherapy Toca 51...
7/10/2018
China's Biopharma Rise: Opportunities and Threats
7/6/2018
CDE Seeks Comments on Draft ICH Guideline Q3D(R1): Elemental Impuritie...
7/6/2018
Adlai Nortye Biopharma $53M in Series B Round
7/6/2018
BIO's China Summit Highlights Trends in BioPharma Market
7/6/2018
Chinese Film Defending Smuggled Indian Anticancers Triggers Intensive ...
Page:
321
/
778
Total number of articles:
23339
:
[First]
[<<]
[319]
[320]
[321]
[322]
[323]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit